Other
National Institute for the Control of Pharmaceutical and Biological Products, China
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 2
2(50.0%)
Phase 3
1(25.0%)
Phase 1
1(25.0%)
4Total
Phase 2(2)
Phase 3(1)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT01510366Phase 3Completed
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)
Role: collaborator
NCT01056705Phase 2Completed
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)
Role: collaborator
NCT01055990Phase 2Unknown
Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Role: collaborator
NCT01048190Phase 1Completed
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains
Role: collaborator
All 4 trials loaded